Market Tracker

01/28 6:05pm ET

Incyte Corp (NASDAQ:INCY)

During the Trading Day
81.44 -1.63 / -1.96%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
82.00 +0.56 / +0.69%
 
Volume: 59.2K

Today’s Trading

Previous close83.07
Today’s open83.51
Day’s range80.44 - 84.73
Volume1,540,206
Average volume (3 months)1,373,386
Market cap$14.0B
Dividend yield--
Data as of 4:00pm ET, 01/28/2015

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+79.57%
Earnings growth (next 5 years)+39.50%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-1.24-0.74%
BMRNBiomarin Pharmaceuti...-2.33-2.34%
MNKMallinckrodt Plc-1.48-1.38%
ENDPEndo International P...+1.46+1.84%
Data as of 4:01pm ET, 01/28/2015

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts